Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans

Eur J Clin Invest. 1996 Nov;26(11):960-5. doi: 10.1046/j.1365-2362.1996.2030543.x.

Abstract

The purpose of this work was to examine in an open, randomized parallel-group study whether an intervention programme directed towards hypercholesterolaemia, smoking and diabetes mellitus in treated hypertensive men was associated with less complex formation between low-density lipoprotein (LDL) and human arterial proteoglycans than was the case with usual care. The intervention consisted mainly of non-pharmacological treatment, but drug therapy could be instituted to achieve the treatment goals in the intervention group. The intervention programme was associated with a significant reduction in body mass index, and 46% of the patients were on lipid-lowering medication at the follow-up examination. The net differences were (intervention--usual care): change in serum LDL-cholesterol, -0.48 mmol L-1 (95% confidence interval -0.84 to -0.11 mmol L-1), precipitated LDL-cholesterol, -5.5 micrograms (95% CI -9.0 to -1.1 micrograms). The latter remained after adjustment for the difference in serum LDL-cholesterol between groups. Our conclusion is that the multifactorial risk factor treatment programme was associated with a reduced tendency of LDL to form complexes with human arterial proteoglycans.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Arteries / chemistry
  • Body Mass Index
  • Cholesterol, LDL / blood
  • Cholesterol, LDL / metabolism
  • Humans
  • Hypercholesterolemia / metabolism
  • Hypertension / blood*
  • Lipids / blood
  • Lipoproteins, LDL / blood*
  • Male
  • Middle Aged
  • Proteoglycans / blood*
  • Proteoglycans / metabolism
  • Risk Factors
  • Smoking Cessation

Substances

  • Cholesterol, LDL
  • Lipids
  • Lipoproteins, LDL
  • Proteoglycans